News

Regeneron Pharmaceuticals was outbid in its effort to buy 23andMe by a nonprofit led by the bankrupt genetics testing company’s co-founder. California-based TTAM Research Institute, led by Anne ...
The agency cleared CSL’s hereditary angioedema drug days after “resource constraints” delayed a rival medicine. Elsewhere, ...
UK regulators on Tuesday fined 23andMe 2.31 million pounds ($3.1 million) for data privacy violations stemming from the ...
Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...
Me's Interim CEO Joe Selsavage said 1.9 million customers have asked the company delete their data since March.
New York and 27 other states sued bankrupt genetic testing company 23andMe to block the sale of 15 million customers' ...
Twenty-seven states and the District of Columbia took legal action this week against 23andMe in the U.S. Bankruptcy Court for ...